How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Randox Laboratories, Limited in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
18 clearance records and 13 recall records in the covered releases, across 1 source company names and 13 product codes. Dated history runs from Sep 9, 2004 to Jan 23, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 1 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Evidence MultiSTAT DOA Urine MultiPlexK250741 · DJG | Randox Laboratories Limited | 510(k) | Jan 23, 2026FDA decision date |
| Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403Z-1017-2025 · DFC | Randox Laboratories, Limited | Recall | Jan 23, 2025FDA classification date |
| Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757Z-1018-2025 · DFC | Randox Laboratories, Limited | Recall | Jan 23, 2025FDA classification date |
| Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATK220451 · DJG | Randox Laboratories Limited | 510(k) | Oct 5, 2023FDA decision date |
| Evidence MultiSTAT DOA Urine MultiPlexK221550 · DJG | Randox Laboratories Limited | 510(k) | Oct 5, 2023FDA decision date |
| RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Product Usage: A fully automated, random access, cl…Z-1349-2020 · JJE | Randox Laboratories, Limited | Recall | Feb 24, 2020FDA classification date |
| Randox Liquid Cardiac Controls Catalogue Number CQ5051Z-0412-2020 · JJY | Randox Laboratories, Limited | Recall | Nov 15, 2019FDA record creation date |
| Randox Liquid Cardiac Controls Catalogue Number CQ5052.Z-0413-2020 · JJY | Randox Laboratories, Limited | Recall | Nov 15, 2019FDA record creation date |
| Randox Liquid Cardiac Controls Catalogue Numbers CQ5053.Z-0414-2020 · JJY | Randox Laboratories, Limited | Recall | Nov 15, 2019FDA record creation date |
| RANDOX NEFA (Non-Esterified Fatty Acids) FA115 Lot 485343, GTIN: 5055273203066.Z-0367-2020 · JLG | Randox Laboratories, Limited | Recall | Nov 13, 2019FDA record creation date |
| Assayed Bovine Multi-Sera Level 1, Model No. AL1027Z-2207-2019 · JJY | Randox Laboratories, Limited | Recall | Aug 7, 2019FDA record creation date |
| Human Assayed Multi-Sera Level 2, Model NO. HN1530 Product Usage: This product is intended for in vitro diagnostic use, in the quality control …Z-2150-2019 · JJY | Randox Laboratories, Limited | Recall | Aug 6, 2019FDA record creation date |
| RX Daytona, Model Nos. RX4040 and RX4041Z-2083-2019 · JJE | Randox Laboratories, Limited | Recall | Jul 25, 2019FDA record creation date |
| RX Imola, Model Nos. RX4900Z-2084-2019 · JJE | Randox Laboratories, Limited | Recall | Jul 25, 2019FDA record creation date |
| Liquid Cardiac Control CQ5053Z-0937-2018 · JJY | Randox Laboratories, Limited | Recall | Mar 9, 2018FDA record creation date |
| Randox RX Daytona Plus Alkaline Phosphatase (ALP)K162275 · CJE | Randox Laboratories Limited | 510(k) | Apr 21, 2017FDA decision date |
| Direct LDL Cholesterol (LDL)K161691 · MRR | Randox Laboratories Limited | 510(k) | Mar 20, 2017FDA decision date |
| Magnesium on RX Imola analyser IVDZ-0725-2017 · JGJ | Randox Laboratories, Limited | Recall | Dec 8, 2016FDA record creation date |
| Direct BilirubinK152343 · JFM | Randox Laboratories Limited | 510(k) | Feb 16, 2016FDA decision date |
| Total BilirubinK152344 · JFM | Randox Laboratories Limited | 510(k) | Jan 28, 2016FDA decision date |
| TriglyceridesK150819 · CDT | Randox Laboratories Limited | 510(k) | Aug 6, 2015FDA decision date |
| LIQUID ASSAYED CHEMISTRY CONTROL PREMIUM PLUS LEVEL 1,2 AND LEVEL 3.K140971 · JJY | Randox Laboratories Limited | 510(k) | Dec 8, 2014FDA decision date |
| RANDOX ALDOLASE CALIBRATION SERUMK142181 · JIT | Randox Laboratories Limited | 510(k) | Sep 18, 2014FDA decision date |
| RANDOX IMMUNOASSAY PREMIUM PLUS CONTROL LEVELS 1,2 AND LEVEL 3 AND IMMUNOASSAY PREMIUM PLUS TRI-LEVEL CONTROLK140522 · JJY | Randox Laboratories Limited | 510(k) | May 22, 2014FDA decision date |
| RANDOX AMMONIA ETHANOL CONTROL LEVELS 1, 2 AND LEVEL 3K140393 · JJY | Randox Laboratories Limited | 510(k) | Mar 25, 2014FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.